Abstract
“Making the Case for Functional Proteomics” first differentiates the Functional Proteome from the products of genetic protein expression. Qualitatively, the prevalence of posttranslational modifications (PTMs) virtually insures that individual, functional proteins do not equate to their genetic expression counterparts. Quantitatively, considering the frequency of PTMs and a conservative estimate of the number of functional entities arising from protein interactions, the size of the Functional Proteome exceeds that of the human genome by at least two orders of magnitude. The human genome does not, cannot, map the Functional Proteome. Further, the collective genome of the human microbiome dwarfs the human genome. With these facts established, “Making the Case…” proceeds to examine Functional Proteomics (of which both “gene expression” and “epigenetics” are but parts of a larger whole) within the context of Systems Biology, concluding that functionally related networks comprise the dominant motif for biological activity. Creating just such a network focus is essential in not only expanding basic knowledge but also in applying that knowledge in the pragmatic efforts of drug and biomarker development. Outlines for development of drugs and biomarkers, as well as the realization of precision medicine, within a functional proteomics-based, network motif are provided. The chapter proceeds to asses both the knowledge base and the tools to fully embrace Functional Proteomics. Given the decades-long infatuation with the reductionism of genomics, it is not surprising that both the proteomics knowledge base and tools are assessed as poor to fair. However, even a minor shift in research funding and a renewed challenge to methods developers will rapidly improve the current situation. Adoption of the included “Roadmap” will realistically make the twenty-first century the century of a long-awaited revolution in biology.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Pundir S, Martin M, O’Donovan C (2017) UniProt protein knowledgebase. Methods Mol Biol 1558:41–55. https://doi.org/10.1007/978-1-4939-6783-4_2
Savage N (2015) Proteomics: high-protein research. Nature 527:S6. https://doi.org/10.1038/527S6a
Pennisi E (2012) ENCODE project writes eulogy for junk DNA. Science 337(6099):1159–1161. https://doi.org/10.1126/science.337.6099.1159
Ezkurdia I, Juan D, Rodriguez JM, Frankish A, Diekhans M, Harrow J, Vazquez J, Valencia A, Tress ML (2014) Multiple evidence strands suggest that there may be as few as 19 000 human protein-coding genes. Hum Mol Genet 23(22):5866–5878
Ponomarenko EA, Poverennaya EV, Ilgisonis EV, Pyatnitskiy MA, Kopylov AT, Zgoda VG, Lisitsa AV, Archakov AI (2016) The size of the human proteome: the width and depth. Int J Anal Chem 2016:7436849
Collins FS (2006) The language of god. Francis S. Collins on unveiling the human genome. Free Press, New York, p 1–3
Ball P (2010) Bursting the genomics bubble. Nature. https://www.nature.com/news/2010/100331/full/news.2010.145.html. https://doi.org/10.1038/news.2010.145
Gisler M (2010) The rise and fall of the human genome project. MIT Technology Review
Weston AD, Hood L (2004) Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res 3:179–196
Butcher EC, Berg EL, Kunkel EJ (2004) Systems biology in drug discovery. Nat Biotechnol 22:1253–1259. https://doi.org/10.1038/nbt1017
Perkins RC. Paul Kenis, Deborah Berthhold & Sarah-Ellen Leonard, University of Illinois, Urbana/Champaign; Jonathan Lee, recently of Eli Lily; and Ray Perkins, New Liberty Proteomics
Strimbu K, Tavel JA (2010) What are biomarkers? Curr Opin HIV AIDS 5(6):463–466
Berger D (1999) A brief history of medical diagnosis and the birth of the clinical laboratory. MLO Med Lab Obs 31(7). 28–30, 32, 34–40
FDA (2018.) In vitro diagnostics. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/default.htm
Kuruc M (2017) Stroma liquid biopsy—biomarkers of the dysregulation of the serum proteome in cancer First presented at NJ cancer Retreat, May 25, 2017 New Brunswick, NJ USA. https://www.biotechsupportgroup.com/v/vspfiles/templates/257/pdf/NJ%20Cancer%20Retreat%20Stroma%20Liquid%20Biopsy%20Poster.pdf
Lowe D (2016) In the pipeline: precision oncology isn’t quite there yet Science Translational Medicine weblog, Lowe D (2016). http://blogs.sciencemag.org/pipeline/archives/2016/09/12/precision-oncology-isnt-quite-there-yet
Gigerenzer G (2014) Risk savvy. Penguin Group, New York, NY
Booth B, Zemmel R (2004) Opinion: prospects for productivity. Nat Rev Drug Discov 3:451–456. https://doi.org/10.1038/nrd1384
Scannell JW, Blanckley A, Boldon H, Warrington B (2012) Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov 11. https://doi.org/10.1038/nrd3681
Lawrence MS, Stoianov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL et al (2013) Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499. https://doi.org/10.1038/nature12213
Swinney D (2013) Phenotypic vs. target-based drug discovery for first-in-class medicines. Clin Pharmacol Ther 93(4):299–301
Moffat JG, Vincent F, Lee JA, Eder J, Prunotto M (2017) Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nat Rev Drug Discov 16:531–543. https://doi.org/10.1038/nrd.2017.111
Bray M-A, Singh S, Han H, Davis CT, Borgeson B, Hartland C, Kost-Alimova M, Gustafsdottir SM, Gibson CC, Carpenter AE (2016) Cell painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes. Nat Protoc 11:1757–1774. https://doi.org/10.1038/nprot.2016.105
Avior Y, Sagi I, Benvenisty N (2016) Pluripotent stem cells in disease modelling and drug discovery. Nat Rev Mol Cell Biol 17. https://doi.org/10.1038/nrm.2015.27
Esch EW, Bahinski A, Huh D (2015) Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov 14(4). https://doi.org/10.1038/nrd4539
Boran AD, Ivengar R (2010) Systems approaches to polypharmacology and drug discovery. Curr Opin Drug Discov Devel 13(3):297–309
Ashley EA (2016) Towards precision medicine. Nat Rev Genet 17. https://doi.org/10.1038/nrg.2016.86
Bandolier (2007) The Oxford league table of analgesic efficacy. http://www.bandolier.org.uk/booth/painpag/Acutrev/Analgesics/lftab.html
Schork NJ (2015) Personalized medicine: time for one-person trials. Nature 520:609–611. https://doi.org/10.1038/520609a
Prasad V (2016) Perspective: the precision-oncology illusion. Nat Biotechnol 537(S63). https://doi.org/10.1038/537S63a
Brock A, Huang S (2017) Precision oncology: between vaguely right and precisely wrong. Cancer Res. https://doi.org/10.1158/0008-5472.CAN-17-0448
HUPO (2016) The human proteome project. https://hupo.org/human-proteome-project
Zhang Y, Fonslow BR, Shan B, Baek M-C, Yates JR (2013) Protein analysis by shotgun/bottom-up proteomics. Chem Rev 113(4):2343–2394. https://doi.org/10.1021/cr3003533
Catherman AD, Skinner OS, Kelleher NL (2014) Top down proteomics: facts and perspectives. Biochem Biophys Res Commun 445(4):683–693. https://doi.org/10.1016/j.bbrc.2014.02.041
Solier C, Langen H (2014) Antibody-based proteomics and biomarker research—current status and limitations. Proteomics 14(6):774–783. https://doi.org/10.1002/pmic.201300334
Wasinger VC, Zeng M, Yau Y (2013) Current status and advances in quantitative proteomic mass spectrometry. Int J Proteomics 2013:180605
Wolf-Yadlin A, Hautaniemi S, Lauffenbuger DA, White FM (2007) Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc Natl Acad Sci U S A 104(14):5860–5865. https://doi.org/10.1073/pnas.0608638104
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The protein data bank. Nucleic Acids Res 28(1):235–242
Wang H, Wang J (2017) How cryo-electron microscopy and X-ray crystallography complement each other. Protein Sci 26(1):32–39. https://doi.org/10.1002/pro.3022
MSU 900 MHz NMR sample requirements. https://www2.chemistry.msu.edu/facilities/nmr/900mhz/MCSB_NMR_sample.html
Claxton DP, Kazmier K, Mishra S, Mchaourab HS (2015) Navigating membrane protein structure, dynamics, and energy landscapes using spin labeling and EPR spectroscopy. Methods Enzymol 564:349–387. https://doi.org/10.1016/bs.mie.2015.07.026
Yang Y, Ramelot TA, McCarrick RM, Ni S, Feldmann EA et al (2010) Combining NMR and EPR methods for Homodimer protein structure determination. J Am Chem Soc 132(34). https://doi.org/10.1021/ja105080h
Stadler C, Rexhepaj E, Singan VR, Murphy RF, Pepperkok R, Uhlén M, Simpson JC, Lundberg E (2013) Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells. Nat Methods 10:315–323. https://doi.org/10.1038/nmeth.2377
von Mering C, Krause R, Snel B, Cornell M, Oliver SG, Fields S, Bork P (2002) Comparative assessment of large-scale data sets of protein–protein interactions. Nat Biotechnol 417:399–403
Braun P, Tasan M, Dreze M, Barrios-Rodiles M, Lemmens I, Yu H, Sahalie JM, Murray RR, Roncari L, A-Sd S, Venkatesan K, Rual J-F, Cusick ME, Pawson T, Hill DE, Tavernier J, Wrana JL, Roth FP, Vidal M (2009) An experimentally derived confidence score for binary protein-protein interactions. Nat Methods 6(1):91–97. https://doi.org/10.1038/nmeth.1281
Rao VS, Srinivas K, Sujini GN, Kumar GNS (2014) Protein-protein interaction detection: methods and analysis. Int J Proteomics 2014:12. https://doi.org/10.1155/2014/147648
Klare J (2013) Site-directed spin labeling EPR spectroscopy in protein research. Biol Chem 394(10):1281–1300. https://doi.org/10.1515/hsz-2013-0155J
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Perkins, R.C. (2019). Making the Case for Functional Proteomics. In: Wang, X., Kuruc, M. (eds) Functional Proteomics. Methods in Molecular Biology, vol 1871. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8814-3_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-8814-3_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-8813-6
Online ISBN: 978-1-4939-8814-3
eBook Packages: Springer Protocols